In this video, Alicia Morgans, MD, discusses a study on the association of intermittent or continuous androgen deprivation therapy with cardiovascular disease and endocrine/metabolic disorders in patients with nonmetastatic prostate cancer.
Morgans, a medical oncologist at Dana-Farber Cancer Institute, co-presented the study at ASCO Genitourinary Cancers Symposium that involved looking for the incidence of major adverse cardiac events in these patients, and compared the rates of these and the development of major endocrine disorders, finding a higher rate of patients with cardiac events.
“When

kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh lisa208 lisa209 lisa210